Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-11

Clinical Trial Update: Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF) [NA]

View source ↗

Summary

A clinical trial evaluating whether a quadriceps-strengthening exoskeleton after total knee arthroplasty reduces transfer to extended care facilities has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Primary Knee Replacement Surgery | NA | Status: WITHDRAWN